Scienture Holdings Inc
Research Scienture Holdings Inc (SCNX) on Bullrun: market cap USD 14.51M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSCNX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencyUSD
- Market capUSD 14.51M
- Financial periodFY2025
- RevenueUSD 431.61K
- Revenue growth215.9%
- Net income-USD 41.51M
- Gross margin76.8%
Valuation Snapshot
latest market cap is USD 14.51M.
About Scienture Holdings Inc
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy;
Frequently asked questions
What is Scienture Holdings Inc's market cap?
Scienture Holdings Inc's market capitalization is USD 14.51M.
What does Scienture Holdings Inc do?
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.